Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR)

Historical Holders from Q4 2023 to Q3 2025

Symbol
JSPR on Nasdaq
Type / Class
Equity / Common Stock, $0.001 Par Value
Shares outstanding
27,913,938
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
20,155,361
Holdings value
$47,814,876
% of all portfolios
0%
Number of holders
60
Number of buys
31
Number of sells
-37
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Velan Capital Investment Management LP 9.6% $7,578,242 2,668,395 Velan Capital Investment Management LP 19 Sep 2025
T. Rowe Price Investment Management, Inc. 7.1% $4,897,117 2,057,612 T. Rowe Price Investment Management, Inc. 30 Sep 2025
ACORN BIOVENTURES, L.P. 6.4% $4,162,526 1,786,492 Anders Hove 01 Dec 2025
Soleus Capital Master Fund, L.P. 9.96% $7,068,607 1,494,420 Soleus Capital Management, L.P. 31 Dec 2024
KINGDON CAPITAL MANAGEMENT, L.L.C. 4.7% -8% $3,153,131 +$1,332,431 1,324,845 +73% Kingdon Capital Management, L.L.C. 30 Sep 2025
Qiming U.S. Healthcare Fund II, L.P. 3.3% $2,210,934 928,964 Qiming U.S. Healthcare Fund II, L.P. 30 Sep 2025
MORGAN STANLEY 2.8% -44% $1,867,415 +$62,296 784,628 +3.5% Morgan Stanley 30 Sep 2025
BlackRock, Inc. 1.5% $1,252,311 225,605 BlackRock, Inc. 30 Jun 2025

Institutional Holders of Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 20,155,361 $47,814,876 +$13,375,640 $2.38 60
2025 Q2 12,514,434 $69,456,410 -$2,535,024 $5.55 63
2025 Q1 13,034,173 $56,047,183 -$70,633,595 $4.3 66
2024 Q4 15,646,434 $334,368,683 +$15,008,656 $21.38 84
2024 Q3 14,676,954 $274,620,688 -$5,485,865 $18.81 77
2024 Q2 14,557,013 $329,580,756 +$34,893,415 $22.7 67
2024 Q1 12,950,959 $379,146,145 +$364,621,578 $29.36 56
2023 Q4 494,706 $390,323 +$390,323 $0.789 1